Through comparing ‘HCC’ CD133+ and ‘normal’ CD133+ cells, we identify SPINK1 to be preferentially enriched in CD133 + HCC and to correlate with a poorly differentiated phenotype in mouse/human developing livers as well as aggressive cancer features in HCC clinical samples. Here, SPINK1 is linked to cancer.